Bristol Myers Squibb (CELG-RI) Current Taxes (2009 - 2019)

Bristol Myers Squibb (CELG-RI) posted quarterly Current Taxes of $525.0 million for Q1 2019, up 77.36% YoY from $296.0 million in Q1 2018, and up 31.91% sequentially from $398.0 million in Q4 2018.

Bristol Myers Squibb (CELG-RI) Current Taxes (2009 - 2019) Analysis & Trends

Bristol Myers Squibb has disclosed Current Taxes across 11 years of filings, most recently posting $525.0 million for Q1 2019.

  • In Q1 2019, Current Taxes rose 77.36% year-over-year to $525.0 million; the TTM figure through Mar 2019 stood at $525.0 million (up 77.36% YoY), while the FY2018 annual figure was $398.0 million, up 72.29% from the prior year.
  • Current Taxes advanced to $525.0 million in Q1 2019, from $398.0 million in the prior quarter.
  • Over the last five years, Current Taxes for CELG-RI reached as high as $572.0 million in Q4 2015 and fell as low as $98.0 million in Q2 2015.
  • The 5-year median for Current Taxes is $291.0 million (2017), against an average of $295.9 million.
  • Annual changes were most pronounced in 2015 — Current Taxes soared 118.32% — and 2016, when it plunged 73.43%.
  • A 5-year view of Current Taxes shows it stood at $572.0 million in 2015, then sank by 73.43% to $152.0 million in 2016, then soared by 51.97% to $231.0 million in 2017, then jumped by 72.29% to $398.0 million in 2018, then surged by 31.91% to $525.0 million in 2019.
  • According to Business Quant data, Current Taxes over the past three periods registered $525.0 million, $398.0 million, and $355.0 million for Q1 2019, Q4 2018, and Q3 2018 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 1.09 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -1.30 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 3.95 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn -
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn -
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 3.13 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Bristol Myers Squibb 244.56 Mn -10.21 Bn 8.07 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2019 525.00 Mn
Dec 31, 2018 398.00 Mn
Sep 30, 2018 355.00 Mn
Jun 30, 2018 373.00 Mn
Mar 31, 2018 296.00 Mn
Dec 31, 2017 231.00 Mn
Sep 30, 2017 213.00 Mn
Jun 30, 2017 291.00 Mn
Mar 31, 2017 180.00 Mn
Dec 31, 2016 152.00 Mn
Sep 30, 2016 312.00 Mn
Jun 30, 2016 164.00 Mn
Mar 31, 2016 472.00 Mn
Dec 31, 2015 572.00 Mn
Sep 30, 2015 179.00 Mn
Jun 30, 2015 98.00 Mn
Mar 31, 2015 220.00 Mn
Dec 31, 2014 262.00 Mn
Sep 30, 2014 312.00 Mn
Jun 30, 2014 204.00 Mn